Prot#ISIS 766720-CS3: An Open-Label Extension Trial of IONIS GHR-LRX, an Antisense Inhibitor of the Growth Hormone Receptor administered monthly subcutaneously to Patients with Acromegaly Being Treated with Long-acting Somatostatin Receptor Ligands (SRL)"